General Information
Product name
Cephalexin for Oral Suspension, USP
Chemical name
(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic
CAS No.
23325-78-2
1.2.1 Relevant identified uses
Semisynthetic cephalosporin antibiotic, administered orally
Emergency telephone
1-888-838-2872
Icons in SDS
Company Information
company name
TEVA Pharmaceuticals
Section 2
SECTION 2: Hazards identification
Emergency Overview: Serious acute hypersensitivity reactions to cephalosporins and penicillin may require the epinephrine and other emergency measures. The health hazards associated with this mixture have not been thoroughly investigated. The signs and symptoms of exposure listed below are based upon potential health effects from the active pharmaceutical ingredient contained in this formula unless otherwise noted.
Principle Routes of Exposure
Eyes: Possible mild to moderate irritant. Skin: Possible mild irritant Ingestion: Clinical Route Inhalation: Not expected Page 2 of 6 Page 3 of 6 Signs and Symptoms of Over Exposure: None expected from incidental contact. Clinically, overdosage may include symptoms of nausea, vomiting, epigastric distress, diarrhea, and/or hematuria. Carcinogenicity: No carcinogenicity data available. Refer to Section 11, Toxicological Information. . NTP: Not Listed IARC: Not Listed
Medical Conditions Generally Aggravated by Exposure
Hypersensitivity to final formulation or any of its ingredients. Hypersensitivity reactions to cephalosporins and penicillin may develop.